Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Routbort

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.
Archives of Pathology & Laboratory Medicine|January 25, 2021
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation SequencingNisha S Ramani, Keyur P Patel, Mark J Routbort, et al.
Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 10, 2015
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2018
Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology AssaysJason D Merker, Kelly Devereaux, A John Iafrate, et al.
Bone Marrow Transplantation|January 7, 2022
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantSiba El Hussein, Courtney D DiNardo, Koichi Takahashi, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2019
Microsatellite Instability Occurs in a Subset of Follicular Thyroid CancersLuke K Genutis, Jerneja Tomsic, Ralf A Bundschuh, et al.
Oncotarget|February 18, 2016
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRASRashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Cameron C Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumorsRashmi S Goswami, Keyur P Patel, Rajesh R Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2022
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromesAli Sakhdari, Caleb Class, Guillermo Montalban-Bravo, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.
Archives of Pathology & Laboratory Medicine|January 25, 2021
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation SequencingNisha S Ramani, Keyur P Patel, Mark J Routbort, et al.
Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 10, 2015
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2018
Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology AssaysJason D Merker, Kelly Devereaux, A John Iafrate, et al.
Bone Marrow Transplantation|January 7, 2022
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantSiba El Hussein, Courtney D DiNardo, Koichi Takahashi, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2019
Microsatellite Instability Occurs in a Subset of Follicular Thyroid CancersLuke K Genutis, Jerneja Tomsic, Ralf A Bundschuh, et al.
Oncotarget|February 18, 2016
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRASRashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Cameron C Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumorsRashmi S Goswami, Keyur P Patel, Rajesh R Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2022
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromesAli Sakhdari, Caleb Class, Guillermo Montalban-Bravo, et al.
Pageof 18